Twenty Years of the SFA

Posts Tagged ‘Brandi Felser’

Twenty Years of the SFA

By Brandi Felser, Executive Director Twenty years later, SFA continues to be a voice and leader for the sarcoma community. Twenty years ago, before SFA, not much attention was paid to sarcoma. There were few treatment options, and no organization or institution focused on developing new therapies or expediting new treatments for patients. Sarcoma was a forgotten cancer. Fast forward 20 years. Sarcoma awareness has substantially increased, more, though not nearly enough, therapies are available, and innovative and novel agents such as immune-oncology are beginning to be applied to sarcoma. And SFA has shown that we have the ability to…  Read More »

The Power of the Sarcoma Community

By Brandi Felser, Executive Director In my very first days on the job as the new Executive Director of the Sarcoma Foundation of America, I had the opportunity to experience first-hand the power of the sarcoma community. For the first time ever, the US Food and Drug Administration (FDA) was reviewing for approval a proposed drug for the treatment of epithelioid sarcoma, a particularly rare and aggressive subtype of sarcoma. Epithelioid sarcoma has few effective treatment options and patients are often left with little or no hope for long-term survival. As a part of the approval process, the benefits of…  Read More »

Sarcoma Foundation of America Announces Brandi Felser as Executive Director

DAMASCUS, Md. – February 3, 2020 – The Sarcoma Foundation of America (SFA), an organization dedicated to increased research, awareness and advocacy for sarcoma, announces Brandi Felser as its new Executive Director.   Felser joins the SFA with more than 20 years of experience in non-profit development and management.  Felser, most recently Chief Operating Officer – Chief of Staff of the National Breast Cancer Coalition, also brings to the SFA a strong background in cancer research advocacy, making her well positioned to lead the organization’s mission to advocate for sarcoma patients by funding research and increasing awareness about this rare…  Read More »